menu
    • menu

    Company profile for Abivax

    NEW Drugs in Dev: 4
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abivax is mobilizing the body’s natural immune system machinery to treat patients with inflammatory diseases, viral infections and cancer.As a clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to optimize and develop drug candidates to treat ulcerative colitis and other inflammatory diseases (ABX464), HIV (ABX464), and liver cancer (ABX196). Our mission is to utilize Abivax’s drug develo...
    Abivax is mobilizing the body’s natural immune system machinery to treat patients with inflammatory diseases, viral infections and cancer.As a clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to optimize and develop drug candidates to treat ulcerative colitis and other inflammatory diseases (ABX464), HIV (ABX464), and liver cancer (ABX196). Our mission is to utilize Abivax’s drug development platforms to bring innovative and effective solutions to patients in these therapeutic areas with significant unmet needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AbivaxFrance Flag
    Country
    Country
    France
    Address
    Address
    5, rue de la Baume 75008 Paris
    Telephone
    Telephone
    +33 (0) 1 53 83 08 41
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abivax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abivax/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ABIVAX_

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abivax shares soar 23% as media report reignites M&A Chatters
    Abivax shares soar 23% as media report reignites M&A Chatters

    11 Jan 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/abivax-shares-soar-23-media-report-reignites-ma-chatter-2026-01-12/

    REUTERS
    11 Jan 2026
    Share Share
    Abivax Provides 2026 Corporate Outlook
    Abivax Provides 2026 Corporate Outlook

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214893/0/en/Abivax-Provides-2026-Corporate-Outlook.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Abivax To Be Added To Nasdaq Biotechnology Index
    Abivax To Be Added To Nasdaq Biotechnology Index

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3208174/0/en/Abivax-to-be-Added-to-Nasdaq-Biotechnology-Index.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3207315/0/en/Abivax-Announces-Acceptance-of-22-Abstracts-Evaluating-Obefazimod-in-Inflammatory-Bowel-Disease-at-ECCO-2026-Featuring-an-Oral-Presentation-on-Preclinical-Anti-Fibrotic-Findings.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Abivax Presents Third Quarter 2025 Financial Results
    Abivax Presents Third Quarter 2025 Financial Results

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205848/0/en/Abivax-Presents-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Abivax Ph3 Obefazimod Data Show QoL Gains in Ulcerative Colitis
    Abivax Ph3 Obefazimod Data Show QoL Gains in Ulcerative Colitis

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179780/0/en/Abivax-Announces-Patient-Reported-Outcomes-Data-from-the-Phase-3-ABTECT-Induction-Trials-of-Obefazimod-Demonstrating-Significant-Improvements-in-Quality-of-Life-for-Patients-with-M.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search